Document is current
Any future updates will be listed below
-
Authors
Perrard, Nicolas
Stabler, Sarah
Sanges, Sébastien
Terriou, Louis
Lamblin, Catherine
Gaillard, Sacha
Vuotto, Fanny
Chenivesse, Cécile
Mortuaire, Geoffrey
Batteux, Frédéric
Mirgot, Floriane
Collet, Aurore
Lopez, Benjamin
Dubucquoi, Sylvain
Labalette, Myriam
Hachulla, Eric
Launay, David
Lefèvre, Guillaume
-
Funding
Funding for this research was provided by:
Centre Hospitalier Universitaire de Lille
- License Information
-
More Information
Article History
Received: 9 September 2024
Accepted: 27 February 2025
First Online: 17 March 2025
Declarations
:
: G. Lefèvre received consulting fees for advisory boards from Grifols, Biotest, and Takeda; personal fees for meetings from LFB, Octapharma, and Grifols; and research funding from LFB, CSL Behring, Octapharma, Takeda, Vitalaire, and Biotest. C. Chenivesse declares research grants from AstraZeneca, GlaxoSmithKline, Santelys, and Novartis; personal fees from ALK-Abello, AstraZeneca, Boehringer-Ingelheim, Chiesi, Sanofi, and GlaxoSmithKline; and congress support from AstraZeneca, Boehringer Ingelheim, Chiesi, and Novartis, outside the submitted work. F. Vuotto received consulting fees for advisory boards from Takeda and AstraZeneka; and congress support from Gilead and Grifols, outside the submitted work. The rest of the authors declare they have no relevant conflicts of interest.
